Cargando…

Long-Acting FGF21 Inhibits Retinal Vascular Leakage in In Vivo and In Vitro Models

The aim of the current study was to investigate the impact of long-acting fibroblast growth factor 21 (FGF21) on retinal vascular leakage utilizing machine learning and to clarify the mechanism underlying the protection. To assess the effect on retinal vascular leakage, C57BL/6J mice were pre-treate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomita, Yohei, Fu, Zhongjie, Wang, Zhongxiao, Cakir, Bertan, Cho, Steve S., Britton, William, Sun, Ye, Hellström, Ann, Talukdar, Saswata, Smith, Lois E.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072824/ https://www.ncbi.nlm.nih.gov/pubmed/32054022 http://dx.doi.org/10.3390/ijms21041188

Ejemplares similares

Retinal glial remodeling by FGF21 preserves retinal function during photoreceptor degeneration
por: Fu, Zhongjie, et al.
Publicado: (2021)

Targeting Neurovascular Interaction in Retinal Disorders
por: Fu, Zhongjie, et al.
Publicado: (2020)

FGF21 via mitochondrial lipid oxidation promotes physiological vascularization in a mouse model of Phase I ROP
por: Fu, Zhongjie, et al.
Publicado: (2023)

Dyslipidemia in retinal metabolic disorders
por: Fu, Zhongjie, et al.
Publicado: (2019)

FGF19 and FGF21: In NASH we trust
por: Talukdar, Saswata, et al.
Publicado: (2020)

Photoreceptor glucose metabolism determines normal retinal vascular growth
por: Fu, Zhongjie, et al.
Publicado: (2017)

Müller glial responses compensate for degenerating photoreceptors in retinitis pigmentosa
por: Tomita, Yohei, et al.
Publicado: (2021)

IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants
por: Cakir, Bertan, et al.
Publicado: (2020)

PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates
por: Thompson, W. Clayton, et al.
Publicado: (2016)

Wnt signaling activates MFSD2A to suppress vascular endothelial transcytosis and maintain blood-retinal barrier
por: Wang, Zhongxiao, et al.
Publicado: (2020)

Pharmacokinetics (PK), Pharmacodynamics (PD) and Integrated PK/PD Modeling of a Novel Long Acting FGF21 Clinical Candidate PF-05231023 in Diet-Induced Obese and Leptin-Deficient Obese Mice
por: Weng, Yan, et al.
Publicado: (2015)

Pemafibrate Prevents Retinal Pathological Neovascularization by Increasing FGF21 Level in a Murine Oxygen-Induced Retinopathy Model
por: Tomita, Yohei, et al.
Publicado: (2019)

In vivo noninvasive mitochondrial redox assessment of the optic nerve head to predict disease
por: Cakir, Bertan, et al.
Publicado: (2023)

FGF21 Requires βklotho to Act In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

Adiponectin Mediates Dietary Omega-3 Long-Chain Polyunsaturated Fatty Acid Protection Against Choroidal Neovascularization in Mice
por: Fu, Zhongjie, et al.
Publicado: (2017)

Amino acid transporter SLC38A5 regulates developmental and pathological retinal angiogenesis
por: Wang, Zhongxiao, et al.
Publicado: (2022)

Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing
por: Weng, Yan, et al.
Publicado: (2018)

Fatty acid oxidation and photoreceptor metabolic needs
por: Fu, Zhongjie, et al.
Publicado: (2021)

Retinopathy of prematurity: Metabolic risk factors
por: Fu, Zhongjie, et al.
Publicado: (2022)

Validation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) using retrospective clinical data
por: Pivodic, Aldina, et al.
Publicado: (2020)

Retinal Disease and Metabolism
por: Fu, Zhongjie, et al.
Publicado: (2022)

FGF21 regulates circadian behavior and metabolism by acting on the nervous system
por: Bookout, Angie L., et al.
Publicado: (2013)

FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance
por: Bernardo, Barbara, et al.
Publicado: (2015)

FGF19 subfamily members: FGF19 and FGF21
por: Dolegowska, Katarzyna, et al.
Publicado: (2019)

Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage
por: Jeong, Ji Hoon, et al.
Publicado: (2016)

Effects of the Topical Administration of Semaglutide on Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes
por: Simó, Rafael, et al.
Publicado: (2021)

Association of the Pattern of Retinal Capillary Non-Perfusion and Vascular Leakage with Retinal Neovascularization in Proliferative Diabetic Retinopathy
por: Jung, Eric E., et al.
Publicado: (2021)

Omega-3/Omega-6 Long-Chain Fatty Acid Imbalance in Phase I Retinopathy of Prematurity
por: Fu, Zhongjie, et al.
Publicado: (2022)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
por: Shao, Zhuo, et al.
Publicado: (2021)

Another Kid on the Block: Long-acting FGF21 Analogue to Treat Dyslipidemia and Fatty Liver
por: Yang, Ranyao, et al.
Publicado: (2021)

FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis
por: Mottillo, Emilio P., et al.
Publicado: (2017)

FGF21 and Cardiac Physiopathology
por: Planavila, Anna, et al.
Publicado: (2015)

Müller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage
por: Wang, Juanjuan, et al.
Publicado: (2010)

Therapeutic Effects of a Novel Phenylphthalimide Analog for Corneal Neovascularization and Retinal Vascular Leakage
por: Wang, Bing, et al.
Publicado: (2018)

Hepatocyte growth factor is upregulated in ischemic retina and contributes to retinal vascular leakage and neovascularization
por: Lorenc, Valeria E., et al.
Publicado: (2020)

Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization
por: Huang, Li, et al.
Publicado: (2021)

Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
por: Henriksson, Emma, et al.
Publicado: (2020)

Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue
por: Villarroya, Joan, et al.
Publicado: (2018)

Liver Brain Interactions: Focus on FGF21 a Systematic Review
por: Prida, Eva, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m5asfdil0jiqrka85b8olnk1jo